If you made any changes in Pure these will be visible here soon.

Research Output

2017

The mTOR inhibitor everolimus in combination with azacitidine in patients with relapsed/refractory acute myeloid leukemia: a phase Ib/II study

Tan, P., Tiong, I. S., Fleming, S., Pomilio, G., Cummings, N., Droogleever, M., McManus, J., Schwarer, A., Catalano, J., Patil, S., Avery, S., Spencer, A. & Wei, A., 2017, In : Oncotarget. 8, 32, p. 52269-52280 12 p.

Research output: Contribution to journalArticleResearchpeer-review

Open Access

Treatment of patients with Waldenström macroglobulinaemia: clinical practice guidelines from the Myeloma Foundation of Australia Medical and Scientific Advisory Group

Talaulikar, D., Tam, C. S., Joshua, D. E., Ho, P. J., Szer, J., Quach, H., Spencer, A., Harrison, S. J., Mollee, P., Roberts, A. W., Horvath, N., Lee, C., Zannettino, A. C. W., Brown, R. D., Augustson, B. M., Jaksic, W. J., Gibson, J., Kalff, A., Johnston, A., Trotman, J. & 4 others, Kalro, A., Grigoriadis, G., Ward, C. & Prince, H. M., 1 Jan 2017, In : Internal Medicine Journal. 47, 1, p. 35-49 15 p.

Research output: Contribution to journalArticleOtherpeer-review

7 Citations (Scopus)

β-catenin inhibitor BC2059 is efficacious as monotherapy or in combination with proteasome inhibitor bortezomib in multiple myeloma

Savvidou, I., Khong, T., Cuddihy, A., McLean, C., Horrigan, S. & Spencer, A., 1 Sep 2017, In : Molecular Cancer Therapeutics. 16, 9, p. 1765-1778 14 p.

Research output: Contribution to journalArticleResearchpeer-review

15 Citations (Scopus)
2016

Carfilzomib and dexamethasone versus bortezomib and dexamethasone for patients with relapsed or refractory multiple myeloma (ENDEAVOR): And randomised, phase 3, open-label, multicentre study

Dimopoulos, M. A., Moreau, P., Palumbo, A., Joshua, D. E., Pour, L., Hájek, R., Facon, T., Ludwig, H., Oriol, A., Goldschmidt, H., Rosiñol, L., Straub, J., Suvorov, A., Araujo, C., Rimashevskaya, E., Pika, T., Gaidano, G., Weisel, K. C., Goranova-Marinova, V., Schwarer, A. & 11 others, Minuk, L., Masszi, T., Karamanesht, I., Offidani, M., Hungria, V., Spencer, A., Orlowski, R. Z., Gillenwater, H. H., Mohamed, N., Feng, S. & Chng, W. J., 1 Jan 2016, In : The Lancet Oncology. 17, 1, p. 27-38 12 p.

Research output: Contribution to journalArticleResearchpeer-review

418 Citations (Scopus)

Changes in bone turnover marker levels and clinical outcomes in patients with advanced cancer and bone metastases treated with bone antiresorptive agents

Lipton, A., Smith, M. R., Fizazi, K., Stopeck, A. T., Henry, D. A., Brown, J. E., Shore, N. D., Saad, F., Spencer, A., Zhu, L. & Warner, D. J., 1 Dec 2016, In : Clinical Cancer Research. 22, 23, p. 5713-5721 9 p.

Research output: Contribution to journalArticleResearchpeer-review

Open Access
16 Citations (Scopus)

Daratumumab, bortezomib, and dexamethasone for multiple myeloma

Palumbo, A., Chanan-Khan, A., Weisel, K. C., Nooka, A. K., Masszi, T., Beksac, M., Spicka, I., Hungria, V., Munder, M., Mateos, M-V., Mark, T. M., Qi, M., Schecter, J., Amin, H., Qin, X., Deraedt, W., Ahmadi, T., Spencer, A. & Sonneveld, P., 25 Aug 2016, In : The New England Journal of Medicine. 375, 8, p. 754-766 13 p.

Research output: Contribution to journalArticleResearchpeer-review

613 Citations (Scopus)

Defibrotide for the management of sinusoidal obstruction syndrome in patients who undergo haemopoietic stem cell transplantation

Coutsouvelis, J., Avery, S., Dooley, M., Kirkpatrick, C. & Spencer, A., 1 Nov 2016, In : Cancer Treatment Reviews. 50, p. 200-204 5 p.

Research output: Contribution to journalReview ArticleResearchpeer-review

4 Citations (Scopus)

Design and development of the Australian and New Zealand (ANZ) myeloma and related diseases registry

Bergin, K., Moore, E., McQuilten, Z., Wood, E., Augustson, B., Blacklock, H., Ho, J., Horvath, N., King, T., McNeil, J., Mollee, P., Quach, H., Reid, C. M., Rosengarten, B., Walker, P. & Spencer, A., 9 Nov 2016, In : BMC Medical Research Methodology. 16, 1, 8 p., 151.

Research output: Contribution to journalArticleResearchpeer-review

Open Access
8 Citations (Scopus)

Epigenetic regulation of miRNA-124 and multiple downstream targets is associated with treatment response in myeloid malignancies

Liu, H. B., Pattie, P., Chandrasekara, S., Spencer, A. & Dear, A. E., Sep 2016, In : Oncology Letters. 12, 3, p. 2175-2180 6 p.

Research output: Contribution to journalArticleResearchpeer-review

4 Citations (Scopus)

Epigenetics in the biology and treatment of multiple myeloma

Spencer, A. & Mithraprabhu, S., 2016, In : European Oncology & Haematology. 12, 2, p. 96-102 7 p.

Research output: Contribution to journalReview ArticleOtherpeer-review

Open Access
File

Evaluating results from the multiple myeloma patient subset treated with denosumab or zoledronic acid in a randomized phase 3 trial

Raje, N., Vadhan-Raj, S., Willenbacher, W., Terpos, E., Hungria, V., Spencer, A., Alexeeva, Y., Facon, T., Stewart, A. K., Feng, A., Braun, A., Balakumaran, A. & Roodman, G. D., 8 Jan 2016, In : Blood Cancer Journal. 6, 5 p., e378.

Research output: Contribution to journalArticleResearchpeer-review

Open Access
File
37 Citations (Scopus)

Final overall survival results of a randomized trial comparing bortezomib plus pegylated liposomal doxorubicin with bortezomib alone in patients with relapsed or refractory multiple myeloma

Orlowski, R. Z., Nagler, A., Sonneveld, P., Bladé, J., Hajek, R., Spencer, A., Robak, T., Dmoszynska, A., Horvath, N., Spicka, I., Sutherland, H. J., Suvorov, A. N., Xiu, L., Cakana, A., Parekh, T. & San-Miguel, J. F., 1 Jul 2016, In : Cancer. 122, 13, p. 2050-2056 7 p.

Research output: Contribution to journalArticleResearchpeer-review

Open Access
File
27 Citations (Scopus)

Hierarchy for targeting prosurvival BCL2 family proteins in multiple myeloma: Pivotal role of MCL1

Gong, J. N., Khong, T., Segal, D., Yao, Y., Riffkin, C. D., Garnier, J. M., Lin Khaw, S., Lessene, G., Spencer, A., Herold, M. J., Roberts, A. W. & Huang, D. C. S., 1 Jan 2016, In : Blood. 128, 14, p. 1834-1844 11 p.

Research output: Contribution to journalArticleResearchpeer-review

64 Citations (Scopus)

International Myeloma Working Group consensus criteria for response and minimal residual disease assessment in multiple myeloma

Kumar, S., Paiva, B., Anderson, K. C., Durie, B., Landgren, O., Moreau, P., Munshi, N., Lonial, S., Bladé, J., Mateos, M-V., Dimopoulos, M., Kastritis, E., Boccadoro, M., Orlowski, R., Goldschmidt, H., Spencer, A., Hou, J., Chng, W. J., Usmani, S. Z., Zamagni, E. & 20 others, Shimizu, K., Jagannath, S., Johnsen, H. E., Terpos, E., Reiman, A., Kyle, R. A., Sonneveld, P., Richardson, P. G., McCarthy, P., Ludwig, H., Chen, W., Cavo, M., Harousseau, J-L., Lentzsch, S., Hillengass, J., Palumbo, A., Orfao, A., Rajkumar, S. V., Miguel, J. S. & Avet-Loiseau, H., 1 Aug 2016, In : The Lancet Oncology. 17, 8, p. e328-e346 19 p.

Research output: Contribution to journalReview ArticleResearchpeer-review

636 Citations (Scopus)

Liquid biopsies for liquid tumors: Emerging potential of circulating free nucleic acid evaluation for the management of hematologic malignancies

Hocking, J., Mithraprabhu, S., Kalff, A. & Spencer, A., 1 Jun 2016, In : Cancer Biology and Medicine. 13, 2, p. 215-225 11 p.

Research output: Contribution to journalReview ArticleResearchpeer-review

Open Access
File
20 Citations (Scopus)

Marizomib irreversibly inhibits proteasome to overcome compensatory hyperactivation in multiple myeloma and solid tumour patients

Levin, N., Spencer, A., Harrison, S. J., Chauhan, D., Burrows, F. J., Anderson, K. C., Reich, S. D., Richardson, P. G. & Trikha, M., 1 Sep 2016, In : British Journal of Haematology. 174, 5, p. 711-720 10 p.

Research output: Contribution to journalArticleResearchpeer-review

Open Access
File
22 Citations (Scopus)

Mitochondrial DNA plasticity is an essential inducer of tumorigenesis

Lee, WTY., Cain, JE., Cuddihy, AR., Johnson, J., Dickinson, A., Yeung, K-Y., Kumar, B., Johns, TG., Watkins, DN., Spencer, A. & St John, JC., 2016, In : Cell Death Discovery. 2, p. 1 - 11 11 p., 16016.

Research output: Contribution to journalArticleResearchpeer-review

Open Access
File
15 Citations (Scopus)

Myeloma of the central nervous system - an ongoing conundrum!

Harrison, S. J., Spencer, A. & Quach, H., 2016, In : Leukemia and Lymphoma. 57, 7, p. 1505 - 1506 2 p.

Research output: Contribution to journalComment / DebateOtherpeer-review

1 Citation (Scopus)

Phase i clinical trial of marizomib (NPI-0052) in patients with advanced malignancies including multiple myeloma: Study NPI-0052-102 final results

Harrison, S. J., Mainwaring, P., Price, T., Millward, M. J., Padrik, P., Underhill, C. R., Cannell, P. K., Reich, S. D., Trikha, M. & Spencer, A., 15 Sep 2016, In : Clinical Cancer Research. 22, 18, p. 4559-4566 8 p.

Research output: Contribution to journalArticleResearchpeer-review

Open Access
File
35 Citations (Scopus)

Primary antifungal prophylaxis in adult patients with acute lymphoblastic leukaemia: A multicentre audit

Doan, T. N., Kirkpatrick, C. M. J., Walker, P., Slavin, M. A., Ananda-Rajah, M. R., Morrissey, C. O., Urbancic, K. F., Grigg, A. P., Spencer, A., Szer, J., Seymour, J. F. & Kong, D. C. M., 1 Feb 2016, In : Journal of Antimicrobial Chemotherapy. 71, 2, p. 497-505 9 p., dkv343.

Research output: Contribution to journalArticleResearchpeer-review

Open Access
File
20 Citations (Scopus)

Roar: A Phase Ib Trial of Oral Azacitidine (CC-486) in Combination with Lenalidomide and Dexamethasone (Rd) for Patients with Relapsed and/or Refractory (R/R) Multiple Myeloma Who Have Failed a Prior Lenalidomide-Containing Regimen

Kalff, A., Reed, K., Khong, T. T., Mithraprabhu, S., Ramachandran, M., Reynolds, J., Bergin, K., Thakurta, A., Wang, M., Spencer, A., Guzman, R., Cuoto, S. & Ren, Y., 2 Dec 2016, In : Blood. 128, 22, 1 p., 2121.

Research output: Contribution to journalMeeting AbstractOtherpeer-review

TOP2A a New Predictive Marker of Response to Carfilzomib in Multiple Myeloma

Reale, A., Khong, T., Mithraprabhu, S., Reynolds, J., Ramachandran, M., Savvidou, I., Bergin, K., Hocking, J. & Spencer, A., 2 Dec 2016, In : Blood. 128, 22, 1 p., 4461.

Research output: Contribution to journalMeeting AbstractOtherpeer-review

2015

A rare case of IGH/MYC and IGH/BCL2 double hit primary plasma cell leukemia

Kalff, A., Khong, T., Wall, M., Gorniak, M., Mithraprabhu, S., Campbell, L. J. & Spencer, A., 2015, In : Haematologica: the hematology journal. 100, 2, p. e60-e62 3 p.

Research output: Contribution to journalLetterOtherpeer-review

Open Access
3 Citations (Scopus)

Chemotherapy plus lenalidomide versus autologous transplantation, followed by lenalidomide plus prednisone versus lenalidomide maintenance, in patients with multiple myeloma: A randomised, multicentre, phase 3 trial

Gay, F., Oliva, S., Petrucci, M. T., Conticello, C., Catalano, L., Corradini, P., Siniscalchi, A., Magarotto, V., Pour, L., Carella, A-M., Malfitano, A., Petrò, D., Evangelista, A., Spada, S., Pescosta, N., Omedè, P., Campbell, P., Liberati, A. M., Offidani, M., Ria, R. & 6 others, Pulini, S., Patriarca, F., Hajek, R., Spencer, A., Boccadoro, M. & Palumbo, A., 2015, In : The Lancet Oncology. 16, 16, p. 1617-1629 13 p.

Research output: Contribution to journalArticleResearchpeer-review

168 Citations (Scopus)
1 Citation (Scopus)

Comparison of biosimilar filgrastim with originator filgrastim for peripheral blood stem cell mobilization and engraftment in patients with multiple myeloma undergoing autologous stem cell transplantation

Pham, T., Patil, S., Fleming, S. A., Avery, S., Walker, P. A., Wei, A., Curtis, D. J., Stuart, G., Klarica, D., O'Brien, M., Morris, K., Das, T. P., Bollard, G. M., Muirhead, J., Coutsouvelis, J. & Spencer, A., 2015, In : Transfusion. 55, 11, p. 2709 - 2713 5 p.

Research output: Contribution to journalArticleResearchpeer-review

11 Citations (Scopus)

Cytogenetics and long-term survival of patients with refractory or relapsed and refractory multiple myeloma treated with pomalidomide and low-dose dexamethasone

Dimopoulos, M. A., Weisel, K. C., Song, K. W., Delforge, M., Karlin, L., Goldschmidt, H., Moreau, P., Banos, A., Oriol, A., Garderet, L., Cavo, M. M., Ivanova, V., Alegre, A., Martinez-Lopez, J., Chen, C., Spencer, A., Knop, S., Bahlis, N. J., Renner, C., Yu, X. & 5 others, Hong, K., Sternas, L., Jacques, C., Zaki, M. & San Miguel, J. F., 2015, In : Haematologica: the hematology journal. 100, 10, p. 1327 - 1333 7 p.

Research output: Contribution to journalArticleResearchpeer-review

Open Access
54 Citations (Scopus)

Elotuzumab therapy for relapsed or refractory multiple myeloma

Lonial, S., Dimopoulos, M. A., Palumbo, A., White, D. J., Grosicki, S., Spicka, I., Walter-Croneck, A., Moreau, P., Mateos, M-V., Magen, H., Belch, A. R., Reece, D. E., Beksac, M., Spencer, A., Oakervee, H., Orlowski, R. Z., Taniwaki, M., Rollig, C., Einsele, H., Wu, K. L. & 8 others, Singhal, A., San Miguel, J. F., Matsumoto, M., Katz, J., Bleickardt, E., Poulart, V., Anderson, K. C. & Richardson, P. G., 2015, In : The New England Journal of Medicine. 373, 7, p. 621 - 631 11 p.

Research output: Contribution to journalArticleResearchpeer-review

695 Citations (Scopus)

Maintenance lenalidomide in combination with 5-azacitidine as post-remission therapy for acute myeloid leukaemia

Wei, A., Tan, P. T. G., Perruzza, S. N., Govindaraj, C., Fleming, S. A., McManus, J. F., Avery, S., Patil, S., Stevenson, W. C., Plebanski, M. & Spencer, A., 2015, In : British Journal of Haematology. 169, 2, p. 199 - 210 12 p.

Research output: Contribution to journalArticleResearchpeer-review

16 Citations (Scopus)

Management of systemic AL amyloidosis: Recommendations of the Myeloma Foundation of Australia Medical and Scientific Advisory Group

Weber, N., Mollee, P., Augustson, B., Brown, R., Catley, L., Gibson, J., Harrison, S., Ho, P. J., Horvath, N., Jaksic, W., Joshua, D., Quach, H., Roberts, A. W., Spencer, A., Szer, J., Talaulikar, D., To, B., Zannettino, A. & Prince, H. M., Apr 2015, In : Internal Medicine Journal. 45, 4, p. 371-382 12 p.

Research output: Contribution to journalReview ArticleResearchpeer-review

12 Citations (Scopus)

MDX-1097 induces antibody-dependent cellular cytotoxicity against kappa multiple myeloma cells and its activity is augmented by lenalidomide

Asvadi, P., Cuddihy, A. R., Dunn, R., Jiang, V., Wong, M. X., Jones, D. R., Khong, T. T. F. & Spencer, A., 2015, In : British Journal of Haematology. 169, 3, p. 333 - 343 11 p.

Research output: Contribution to journalArticleResearchpeer-review

4 Citations (Scopus)

Modifying chemotherapeutic management of a patient with Burkitt's lymphoma and pre-existing motor neurone disease

Bortz, H. D., Coutsouvelis, J., Corallo, C., Spencer, A. & Patil, S., 2015, In : Journal of Clinical Pharmacy and Therapeutics. 40, 4, p. 483 - 485 3 p.

Research output: Contribution to journalArticleOther

Phase 1/1B trial of the heat shock protein 90 inhibitor NVP-AUY922 as monotherapy or in combination with bortezomib in patients with relapsed or refractory multiple myeloma

Seggewiss-Bernhardt, R., Bargou, R. C., Goh, Y. T., Stewart, A. K., Spencer, A., Alegre, A., Blade, J., Ottman, O. G., Fernandez-Ibarra, C., Lu, H., Pain, S., Akimov, M. & Iyer, S. P., 2015, In : Cancer. 121, 13, p. 2185 - 2192 8 p.

Research output: Contribution to journalArticleResearchpeer-review

24 Citations (Scopus)

Phase 2 study of dovitinib in patients with relapsed or refractory multiple myeloma with or without t(4;14) translocation

Scheid, C., Reece, D. E., Beksac, M., Spencer, A., Callander, N. S., Sonneveld, P., Kalimi, G., Cai, C., Shi, M. M., Scott, J. W. & Stewart, A. K., 2015, In : European Journal of Haematology. 95, 4, p. 316 - 324 9 p.

Research output: Contribution to journalArticleResearchpeer-review

18 Citations (Scopus)

Revised international staging system for multiple myeloma: a report from international myeloma working group

Palumbo, A., Avet-Loiseau, H., Olivia, S., Lokhorst, H. M., Goldschmidt, H., Rosinol, L., Richardson, P. G., Caltagirone, S., Lahuerta, J. J., Facon, T., Bringhen, S., Gay, F., Attal, M., Passera, R., Spencer, A., Offidani, M., Kumar, S. K., Musto, P., Lonial, S., Petrucci, M. T. & 11 others, Orlowski, R. Z., Zamagni, E., Morgan, G., Dimopoulos, M. A., Durie, B. G. M., Anderson, K. C., Sonneveld, P., San Miguel, J. F., Cavo, M. M., Rajkumar, S. V. & Moreau, P., 2015, In : Journal of Clinical Oncology. 33, 26, p. 2863 - 2869 7 p.

Research output: Contribution to journalArticleOther

603 Citations (Scopus)

The addition of dexamethasone to bortezomib for patients with relapsed multiple myeloma improves outcome but ongoing maintenance therapy has minimal benefit

Harrison, S. J. A., Quach, H., Link, E. K., Feng, H., Dean, J., Copeman, M. B., van de Velde, H., Schwarer, A., Baker, B., Spencer, A., Catalano, J., Campbell, P., Augustson, B. M., Romeril, K. & Prince, H. M., 2015, In : American Journal of Hematology. 90, 5, p. 86 - 91 6 p.

Research output: Contribution to journalArticleOther

5 Citations (Scopus)

The Frequency of Cytomegalovirus (CMV)-Specific CD8+ T Cells Distinguishes CMV Clinical Outcomes Following Hematopoietic Allogeneic Stem Cell Transplant: A Prospective Multicentre Cohort Study

Yong, M. K., Slavin, M., Ritchie, D., Spencer, A., Cameron, P., Morrissey, O., Cheng, A. C., Samri, A., Carcelain, G., Autran, B. & Lewin, S., 2015, In : Blood. 126, 23

Research output: Contribution to journalMeeting AbstractOtherpeer-review

Open Access

The role of denosumab in the prevention of hypercalcaemia of malignancy in cancer patients with metastatic bone disease

Diel, I. J., Body, J-J., Stopeck, A. T., Vadhan-Raj, S., Spencer, A., Steger, G., von Moos, R., Goldwasser, F., Feng, A. & Braun, A., 2015, In : European Journal of Cancer. 51, 11, p. 1467-1475 9 p.

Research output: Contribution to journalArticleResearchpeer-review

21 Citations (Scopus)

TOP2A knockdown resensitizes carfilzomib-resistant Hmcls to carfilzomib

Reale, A., Khong, T. T., Mithraprabhu, S., Savvidou, I., Ramachandran, M. & Spencer, A., Dec 2015, p. 4215. 1 p.

Research output: Contribution to conferenceAbstract

Treatment of patients with multiple myeloma who are eligible for stem cell transplantation: Position statement of the Myeloma Foundation of Australia Medical and Scientific Advisory Group

Quach, H., Joshua, D., Ho, J., Szer, J., Spencer, A., Harrison, S. J., Mollee, P., Roberts, A. W., Horvath, N., Talulikar, D., To, B., Zannettino, A., Brown, R., Catley, L., Augustson, B., Jaksic, W., Gibson, J. & Prince, H. M., Jan 2015, In : Internal Medicine Journal. 45, 1, p. 94-105 12 p.

Research output: Contribution to journalArticleResearchpeer-review

7 Citations (Scopus)

Treatment of patients with multiple myeloma who are not eligible for stem cell transplantation: Position statement of the myeloma foundation of Australia Medical and Scientific Advisory Group (

Quach, H., Joshua, D. E., Ho, J., Szer, J., Spencer, A., Harrison, S., Mollee, P. N., Roberts, A. W., Horvath, N., Talaulikar, D., To, B., Zannettino, A. C. W., Brown, R. D., Catley, L. P., Augustson, B. M., Jaksic, W. J., Gibson, J. L. & Prince, H. M., 2015, In : Internal Medicine Journal. 45, 3, p. 335-343 9 p.

Research output: Contribution to journalArticleOtherpeer-review

3 Citations (Scopus)
2014
36 Citations (Scopus)

Comparison of the probability of target attainment of anidulafungin against Candida spp. in patients with acute leukaemia

Doan, T. N., Kong, D. C. M., Patel, K., Walker, P. A., Spencer, A. & Kirkpatrick, C. M. J., 2014, In : International Journal of Antimicrobial Agents. 44, 5, p. 450 - 457 8 p.

Research output: Contribution to journalArticleResearchpeer-review

5 Citations (Scopus)

Dual epigenetic targeting with panobinostat and azacitidine in acute myeloid leukemia and high-risk myelodysplastic syndrome

Tan, P., Wei, A., Mithraprabhu, S., Cummings, N. J., Liu, H. B., Perugini, M., Reed, K. D., Avery, S., Patil, S., Walker, P. A., Mollee, P. N., Grigg, A. P., D'Andrea, R. J., Dear, A. E. & Spencer, A., 2014, In : Blood Cancer Journal. 4, 1, p. 1 - 8 8 p., e170.

Research output: Contribution to journalArticleResearchpeer-review

Open Access
73 Citations (Scopus)

Dysregulated Class I histone deacetylases are indicators of poor prognosis in multiple myeloma

Mithraprabhu, S., Kalff, A., Chow, A., Khong, T. T. F. & Spencer, A., 2014, In : Epigenetics. 9, 11, p. 1511 - 1520 10 p.

Research output: Contribution to journalArticleResearchpeer-review

66 Citations (Scopus)

Fludarabine Melphalan reduced-intensity conditioning allotransplanation provides similar disease control in lymphoid and myeloid malignancies: Analysis of 344 patients

Bryant, A., Nivison-Smith, I., Pillai, ES., Kennedy, G., Kalff, A., Ritchie, D., George, B., Hertzberg, M., Patil, S., Spencer, A., Fay, K., Cannell, P., Berkahn, L., Doocey, R., Spearing, R. & Moore, J., Jan 2014, In : Bone Marrow Transplantation. 49, 1, p. 17-23 7 p.

Research output: Contribution to journalArticleResearchpeer-review

Open Access
File
9 Citations (Scopus)

Health economic impact of high-dose versus standard-dose cytarabine induction chemotherapy for acute myeloid leukaemia

Fedele, P., Avery, S., Patil, S., Spencer, A., Haas, M. & Wei, A., 2014, In : Internal Medicine Journal. 44, 8, p. 757 - 763 7 p.

Research output: Contribution to journalArticleResearchpeer-review

7 Citations (Scopus)

International Myeloma Working Group consensus statement for the management, treatment, and supportive care of patients with myeloma not eligible for standard autologous stem-cell transplantation

Palumbo, A., Rajkumar, S. V., San Miguel, J. F., Larocca, A. T., Niesvizky, R., Morgan, G., Landgren, O., Hajek, R., Einsele, H., Anderson, K. C., Dimopoulos, M. A., Richardson, P. G., Cavo, M. M., Spencer, A., Stewart, A. K., Shimizu, K., Lonial, S., Sonneveld, P., Durie, B. G. M., Moreau, P. & 1 others, Orlowski, R. Z., 2014, In : Journal of Clinical Oncology. 32, 6, p. 587-600 14 p.

Research output: Contribution to journalArticleResearchpeer-review

220 Citations (Scopus)

Mechanisms and potential molecular markers of early response to combination epigenetic therapy in patients with myeloid malignancies

Liu, H. B., Urbanavicius, D. B., Tan, P., Spencer, A. & Dear, A. E., 2014, In : International journal of oncology. 45, 4, p. 1742 - 1748 7 p.

Research output: Contribution to journalArticleResearchpeer-review

6 Citations (Scopus)

Outcomes following second allogeneic haematopoietic transplants using fludarabine-melphalan conditioning

Bilmon, I., Nivison-Smith, I., Hertzberg, M. S., Ritchie, D., Greenwood, M. J., Spencer, A., Kennedy, G. A., Bryant, A. & Moore, J., 2014, In : Bone Marrow Transplantation. 49, 6, p. 852 - 853 2 p.

Research output: Contribution to journalLetterOther